To test artificial intelligence (AI)-assisted magnetic resonance imaging (MRI) in detecting disease activity in Multiple Sclerosis, and to determine whether AI impacts MRI review, treatment decisions, costs, and follow-up care

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2025
This article has no abstract
Epistemonikos ID: 8ea2ef5a03c1954da7197d444f089209cc833d12
First added on: Mar 01, 2025